Post LASIK cataract surgery woes

Article

The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, Texas, US offered several tips for achieving better refractive outcomes in this growing population of eyes.

The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, Texas, US offered several tips for achieving better refractive outcomes in this growing population of eyes.

With accurate biometry being a critical factor to achieving precise IOL power calculations, Dr Holladay said that a proprietary diagnostic system (IOLMaster, Carl Zeiss Meditec) should be considered the gold standard for axial length measurement. He also advocated selecting an IOL power calculation formula that includes horizontal corneal diameter for predicting the effective lens position.

Accurate keratometry is the most important problem faced in postLASIK eyes, and it may be best achieved using a tomographer that, in contrast to conventional keratometry and topography, measures the central power (rather than paracentral) and both the front and back surfaces of the cornea (versus front only). Dr Holladay also recommended that all surgeons use a personalized lens constant that will reflect their surgical technique and target mild myopia as the refractive outcome, since aiming for emmetropia leaves a 50:50 chance of a hyperopic result.

Despite these precautions, a secondary procedure to refine results may nevertheless be required, Dr Holladay concluded.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.